Evidence map›Paper›PMID 39614978›Full record

ArticleAMB Express2024

Engineering Komagataella phaffii for ethylene glycol production from xylose.

Clara Vida G C Carneiro, Débora Trichez, Jessica C Bergmann, Viviane Castelo Branco Reis, Nils Wagner, Thomas Walther, João Ricardo Moreira de Almeida

Abstract read
In one paragraph

Article in AMB Express, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Metabolic engineering ofApplied and environmental microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Clara Vida G C CarneiroGraduate Program of Microbial Biology, Institute of Biology, University of Brasília, Brasília, Brazil.
Débora TrichezMicrobial Genetics and Biotechnology Laboratory, Embrapa Agroenergy, Brasília, Brazil.
Jessica C BergmannMicrobial Genetics and Biotechnology Laboratory, Embrapa Agroenergy, Brasília, Brazil.
Viviane Castelo Branco ReisMicrobial Genetics and Biotechnology Laboratory, Embrapa Agroenergy, Brasília, Brazil.
Nils WagnerInstitute of Natural Materials Technology, TU Dresden, Dresden, Germany.
Thomas WaltherInstitute of Natural Materials Technology, TU Dresden, Dresden, Germany.
João Ricardo Moreira de AlmeidaGraduate Program of Microbial Biology, Institute of Biology, University of Brasília, Brasília, Brazil. joao.almeida@embrapa.br.ORCID http://orcid.org/0000-0002-2902-5805

Funding

Fundação de Apoio à Pesquisa do Distrito Federal 76/2021
6 · The paper itself

Abstract

Ethylene glycol (EG) is a versatile molecule produced in the petrochemical industry and is widely used to manufacture plastic polymers, anti-freeze, and automotive fluids. Biotechnological production of EG from xylose, a pentose present in lignocellulose biomass hydrolysates, has been achieved by the engineering of bacteria, such as Escherichia coli and Enterobacter cloacae, and the yeast Saccharomyces cerevisiae with synthetic pathways. In the present work, the Dahms pathway was employed to construct Komagataella phaffii strains capable of producing EG from xylose. Different combinations of the four enzymes that compose the synthetic pathway, namely, xylose dehydrogenase, xylonate dehydratase, dehydro-deoxy-xylonate aldolase, and glycolaldehyde reductase, were successfully expressed in K. phaffii. Increased production of EG (1.31 g/L) was achieved by employing a newly identified xylonate dehydratase (xylD-HL). This xylonate dehydratase allowed 30% higher EG production than a previously known xylonate dehydratase (xylD-CC). Further strain engineering demonstrated that K. phaffii possesses native glycolaldehyde reduction and oxidation activities, which lead to pathway deviation from EG to glycolic acid (GA) production. Finally, cultivation conditions that favor the production of EG over GA were determined.

Indexed as

Ethylene glycolK. PhaffiiMetabolic engineeringSynthetic biologyXylose

Identifiers

PMID39614978
PMCPMC11608209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.